Zydus To Continue Mirabegron Sales

Looks To World-First Dual Shigella-Typhoid Vaccine

 
• By Vibha Ravi
  
Zydus Is Counting On Key Products, Launches For FY26 Growth
Zydus Is Counting On Key Products, Launches For FY26 Growth (Shutterstock)

More from Earnings

More from Strategy